CD274 and triple-negative breast carcinoma: Intriguingly, Qin et al., discovered that normal NPM1 protein specifically binds to PD-L1 promoter in triple-negative breast cancer cells and activates PD-L1 transcription, therefore inhibiting T-cell activity in vitro and in vivo.